{"id":"W4237312607","doi":"10.2165/00128413-200514930-00064","title":"Health Canada has approved a new indication for candesartan cilexetil","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Candesartan; Medicine; Pharmacy; Intensive care medicine; Family medicine; Internal medicine; Angiotensin II; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002375383,0.0001437899,0.0005099634,0.00005965032,0.000112664,0.00002456236,0.00007676255,0.00005618878,0.0001336852],"category_scores_gemma":[0.00009471906,0.0001241575,0.0001694868,0.0001320086,0.00003080831,0.00005400951,0.000009956176,0.000125634,0.00001861353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003968709,"about_ca_system_score_gemma":0.00329708,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1836096,"about_ca_topic_score_gemma":0.2179573,"domain_scores_codex":[0.9987701,0.00003691137,0.0003127214,0.0002271854,0.0003103867,0.000342731],"domain_scores_gemma":[0.9989757,0.0001870517,0.0001005271,0.0002041898,0.00005598289,0.0004765319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004847375,0.0001260945,0.01480138,0.0001489286,0.0001448834,0.00003572328,0.0006724446,0.0000239711,0.0006114568,0.001139203,0.7860627,0.1957485],"study_design_scores_gemma":[0.002558275,0.0001030812,0.02583048,0.00002516863,0.00005189092,0.00007134843,0.00006975823,0.0002426004,0.0006249486,0.00001115649,0.970285,0.000126321],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2274288,0.002534353,0.001588606,0.7535425,0.0005655204,0.0024659,0.00006254976,0.0002042576,0.01160748],"genre_scores_gemma":[0.9586239,0.00005712227,0.001575511,0.02471817,0.0009437452,0.00006171213,0.0001018379,0.00003086547,0.0138871],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7311952,"threshold_uncertainty_score":0.8218268,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03292257216751831,"score_gpt":0.2989812046243451,"score_spread":0.2660586324568268,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}